Is Valneva (VALN) the Best Performing NASDAQ Stock So Far in 2025? - Yahoo Finance
2025-04-01 • Google News
Valneva SE ADR (VALN)
US$ 7.030.57%
Price Chart
Key Statistics
Market Cap
$ 505.6M
P/E Ratio
0.00
Revenue (TTM)
$ 186.06M
Volume
10.86K
52W High
$ 8.66
52W Low
$ 3.62
Dividend Yield
0.00%
Beta
1.09
Technicals
50-Day MA
6.4253
200-Day MA
5.9231
52 Week High
8.661
52 Week Low
3.62
About VALN
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-d.
Employees
713
Headquarters
Saint-Herblain, France
CEO
Mr. Thomas Lingelbach
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg